ASAgneta L. Sunehag

Agneta L. Sunehag

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Agneta L. Sunehag has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effect of ghrelin on glucose regulation in mice

    by Shaji K. Chacko, Morey W. Haymond, Yuxiang Sun, Juan C. Marini, Pieter J. J. Sauer, Xiaojun Ma, Agneta L. Sunehag

    Improvement of glucose metabolism after bariatric surgery appears to be from the composite effect of the alterations in multiple circulating gut hormone concentrations. However, their individual effect on glucose metabolism during different conditions is not clear. The objective of this study was to determine whether ghrelin has an impact on glycogenolysis, gluconeogenesis, and insulin sensitivity (using a mice model). Rate of appearance of glucose, glycogenolysis, and gluconeogenesis were measured in wild-type (WT), ghrelin knockout (ghrelin−/−), and growth hormone secretagogue receptor knockout (Ghsr−/−) mice in the postabsorptive state. The physiological nature of the fasting condition was ascertained by a short-term fast commenced immediately at the end of the dark cycle. Concentrations of glucose and insulin were measured, and insulin resistance and hepatic insulin sensitivity were calculated. Glucose concentrations were not different among the groups during the food-deprived period. However, plasma insulin concentrations were lower in the ghrelin−/− and Ghsr−/− than WT mice. The rates of gluconeogenesis, glycogenolysis, and indexes of insulin sensitivity were higher in the ghrelin−/− and Ghsr−/− than WT mice during the postabsorptive state. Insulin receptor substrate 1 and glucose transporter 2 gene expressions in hepatic tissues of the ghrelin−/− and Ghsr−/− were higher compared with that in WT mice. This study demonstrates that gluconeogenesis and glycogenolysis are increased and insulin sensitivity is improved by the ablation of the ghrelin or growth hormone secretagogue receptor in mice.


  • Strength Exercise Improves Muscle Mass and Hepatic Insulin Sensitivity in Obese Youth

    by Gert-Jan VAN DER Heijden, Zhiyue J. Wang, Zili Chu, Gianna Toffolo, Erica Manesso, Pieter J. J. Sauer, Agneta L. Sunehag

    On, increases lean body mass, and improves insulin sensitivity and glucose metabolism in sedentary obese Hispanic adolescents. Methods: Twelve obese adolescents (age = 15.5 ± 0.5 yr, body mass index = 35.3 ± 0.8 kg·m−2; 40.8% ± 1.5% body fat) completed a 12-wk resistance exercise program (two times 1 h·wk−1, exercising all major muscle groups). At baseline and on completion of the program, body composition was measured by dual-energy x-ray absorptiometry, abdominal fat distribution was measured by magnetic resonance imaging, hepatic and intramyocellular fat was measured by magnetic resonance spectroscopy, peripheral insulin sensitivity was measured by the stable-label intravenous glucose tolerance test, and hepatic insulin sensitivity was measured by the hepatic insulin sensitivity index = 1000/(GPR × fasting insulin). Glucose production rate (GPR), gluconeogenesis, and glycogenolysis were quantified using stable isotope gas chromatography/mass spectrometry techniques. Results: All participants were normoglycemic. The exercise program resulted in significant strength gain in both upper and lower body muscle groups. Body weight increased from 97.0 ± 3.8 to 99.6 ± 4.2 kg (P < 0.01). The major part (∼80%) was accounted for by increased lean body mass (55.7 ± 2.8 to 57.9 ± 3.0 kg, P ≤ 0.01). Total, visceral, hepatic, and intramyocellular fat contents remained unchanged. Hepatic insulin sensitivity increased by 24% ± 9% (P < 0.05), whereas peripheral insulin sensitivity did not change significantly. GPR decreased by 8% ± 1% (P < 0.01) because of a 12% ± 5% decrease in glycogenolysis (P < 0.05). Conclusions: We conclude that a controlled resistance exercise program without weight loss increases strength and lean body mass, improves hepatic insulin sensitivity, and decreases GPR without affecting total fat mass or visceral, hepatic, and intramyocellular fat contents....


  • Open Access

    Twelve weeks of moderate aerobic exercise without dietary intervention or weight loss does not affect 24-h energy expenditure in lean and obese adolescents

    by Gert-Jan van der Heijden, Pieter Jj Sauer, Agneta L Sunehag

    Background: Exercise might have a persistent effect on energy expenditure and fat oxidation, resulting in increased fat loss. However, even without w


  • A 12‐Week Aerobic Exercise Program Reduces Hepatic Fat Accumulation and Insulin Resistance in Obese, Hispanic Adolescents

    by Gert‐Jan van der Heijden, Zhiyue J. Wang, Zili D. Chu, Pieter J.J. Sauer, Morey W. Haymond, Luisa M. Rodriguez, Agneta L. Sunehag

    The rise in obesity‐related morbidity in children and adolescents requires urgent prevention and treatment strategies. Currently, only limited data are available on the effects of exercise programs on insulin resistance, and visceral, hepatic, and intramyocellular fat accumulation. We hypothesized that a 12‐week controlled aerobic exercise program without weight loss reduces visceral, hepatic, and intramyocellular fat content and decreases insulin resistance in sedentary Hispanic adolescents. Twenty‐nine postpubertal (Tanner stage IV and V), Hispanic adolescents, 15 obese (7 boys, 8 girls; 15.6 ± 0.4 years; 33.7 ± 1.1 kg/m2; 38.3 ± 1.5% body fat) and 14 lean (10 boys, 4 girls; 15.1 ± 0.3 years; 20.6 ± 0.8 kg/m2; 18.9 ± 1.5% body fat), completed a 12‐week aerobic exercise program (4 × 30 min/week at ≥70% of peak oxygen consumption (VO2peak)). Measurements of cardiovascular fitness, visceral, hepatic, and intramyocellular fat content (magnetic resonance imaging (MRI)/magnetic resonance spectroscopy (MRS)), and insulin resistance were obtained at baseline and postexercise. In both groups, fitness increased (obese: 13 ± 2%, lean: 16 ± 4%; bothP< 0.01). In obese participants, intramyocellular fat remained unchanged, whereas hepatic fat content decreased from 8.9 ± 3.2 to 5.6 ± 1.8%;P< 0.05 and visceral fat content from 54.7 ± 6.0 to 49.6 ± 5.5 cm2;P< 0.05. Insulin resistance decreased indicated by decreased fasting insulin (21.8 ± 2.7 to 18.2 ± 2.4 µU/ml;P< 0.01) and homeostasis model assessment of insulin resistance (HOMAIR) (4.9 ± 0.7 to 4.1 ± 0.6;P< 0.01). The decrease in visceral fat correlated with the decrease in fasting insulin (R2= 0.40;P< 0.05). No significant changes were observed in any parameter in lean participants except a small increase in lean body mass (LBM). Thus, a controlled aerobic exercise program, without weight loss, reduced hepatic and visceral fat accumulation, and decreased insulin resistance in obese adolescents.


  • Open Access

    Aerobic Exercise Increases Peripheral and Hepatic Insulin Sensitivity in Sedentary Adolescents

    by Gert-Jan van der Heijden, Gianna Toffolo, Erica Manesso, Pieter J. J. Sauer, Agneta L. Sunehag

    Context: Data are limited on the effects of controlled aerobic exercise programs (without weight loss) on insulin sensitivity and glucose metabolism in children and adolescents. Objective: To determine whether a controlled aerobic exercise program (without weight loss) improves peripheral and hepatic insulin sensitivity and affects glucose production (GPR), gluconeogenesis and glycogenolysis in sedentary lean and obese Hispanic adolescents. Patients and Design: Twenty-nine post-pubertal adolescents (14 lean: 15.1 ± 0.3y; 20.6 ± 0.8kg/m2; 18.9±1.5% body fat and 15 obese: 15.6 ± 0.4y; 33.2 ± 0.9kg/m2; 38.4 ± 1.4% body fat) (mean ± SE), completed a 12 wk aerobic exercise program (4 × 30 min/week at ≥70% of VO2 peak). Peripheral and hepatic insulin sensitivity and glucose kinetics were quantified using GCMS pre- and post-exercise. Results: No weight loss occurred. Lean and obese participants complied well with the program (∼90% of the exercise sessions attended, resulting in ∼15% increase in fitness in both groups). Peripheral and hepatic insulin sensitivity were higher in lean than obese adolescents but increased in both groups; peripheral insulin sensitivity by 35 ± 14% (lean) (p < 0.05) and 59 ± 19% (obese) (p < 0.01) and hepatic insulin sensitivity by 19 ± 7% (lean) (p < 0.05) and 23 ± 4% (obese) (p < 0.01). GPR, gluconeogenesis and glycogenolysis did not differ between the groups. GPR decreased slightly, 3 ± 1% (lean) (p < 0.05) and 4 ± 1% (obese) (p < 0.01). Gluconeogenesis remained unchanged, while glycogenolysis decreased slightly in the obese group (p < 0.01). Conclusion: This well accepted aerobic exercise program, without weight loss, is a promising strategy to improve peripheral and hepatic insulin sensitivity in lean and obese sedentary adolescents. The small decrease in GPR is probably of limited clinical relevance. A moderate aerobic exercise program that is well accepted by sedentary Hispanic adolescents significantly increases both peripheral and hepatic insulin sensitivity in lean and obese participants.


  • Short-term High Dietary Fructose Intake had No Effects on Insulin Sensitivity and Secretion or Glucose and Lipid Metabolism in Healthy, Obese Adolescents

    by A L. Sunehag, G. Toffolo, M. Campioni, D.M. Bier, M.W. Haymond

    There is virtually no information on the metabolic impact of dietary fructose intake in adolescents despite their high fructose consumption, particularly via sweetened beverages. To determine the short-term metabolic effects of dietary fructose intake in obese adolescents. Six volunteers (3 M/3 F; 15.2 +/- 0.5 yr; 35 +/- 2 kg/m2; 39 +/- 2% body fat) were studied twice following 7 d of isocaloric, isonitrogenous high carbohydrate (60% CHO; 25% fat) diets with fructose accounting for 6% and 24% of total energy intake, respectively (random order). Insulin sensitivity and secretion were analyzed by the stable labeled intravenous glucose tolerance test and glucose and lipid kinetics using GCMS. A fourfold increase in dietary fructose intake did not affect insulin sensitivity or secretion, glucose kinetics, lipolysis or glucose, insulin, C-peptide, triglycerides, HDL- and LDL-cholesterol concentrations. In the short term, when energy intake is constant, dietary fructose per se is not a contributor to insulin resistance and hypersecretion in obese adolescents.


  • Subcutaneous Infusion and Capillary “Finger Stick” Sampling of Stable Isotope Tracer in Metabolic Studies

    by Paula M Hertel, Shaji K Chacko, Sunita Pal, Agneta L Sunehag, Morey W Haymond

    Metabolic studies utilizing stable isotope tracer in humans have typically used intravenous tracer infusions and venous blood sampling. These studies explore subcutaneous infusion of isotope and “finger stick” capillary blood sampling to measure glucose turnover. Five subjects received simultaneous 8-h infusions of glucose labeled with isotope: [1-13C]glucose subcutaneously and [6,6-2H2]glucose intravenously. At regular intervals, venous and finger stick blood specimens were obtained. Finger stick blood was applied to filter paper. Substrate and isotopic steady state was reached after 7.0 h with both routes of infusion. The isotopic enrichments of finger stick and venous specimens did not differ significantly for the subcutaneously infused [1-13C]glucose (p = 0.33 and p = 0.23, respectively) but the finger stick [6,6-2H2]glucose enrichment was slightly higher (p < 0.03) than that of the venous sample. Using [6,6-2H2]glucose infusion and venous plasma sampling as the reference method, the [1-13C]glucose gave estimates of glucose Ra that were 13% (plasma) and 17% (finger stick) lower (p < 0.001 and p < 0.02, respectively). This difference could be attributed to recycling of 13C label. In conclusion, subcutaneous infusion and finger stick specimen collection onto filter paper represent a potential method of conducting in vivo studies of substrate metabolism outside of a hospital-based research unit.


  • Effects of Dietary Macronutrient Intake on Insulin Sensitivity and Secretion and Glucose and Lipid Metabolism in Healthy, Obese Adolescents

    by Agneta L. Sunehag, Gianna Toffolo, Marco Campioni, Dennis M. Bier, Morey W. Haymond

    Adolescent obesity is a serious public health concern. The aim of the study was to determine whether obese adolescents can adapt metabolically to changes in dietary macronutrient intake. Using a random cross-over design, 13 healthy obese volunteers (six boys and seven girls; age, 14.7 +/- 0.3 yr; body mass index, 34 +/- 1 kg/m2; body fat, 42 +/- 1%) were studied twice after 7 d of isocaloric, isonitrogenous diets with 60% carbohydrate (CHO) and 25% fat (high CHO), or 30% CHO and 55% fat (low CHO). Glucose metabolism, insulin sensitivity, and first- and second-phase insulin secretory indices were measured by stable isotope techniques and the stable labeled iv glucose tolerance test. The results were compared with those of previously studied lean adolescents. Obese adolescents increased first- and second-phase insulin secretory indices by 18 (P = 0.05) and 36% (P = 0.05), respectively, to maintain normoglycemia during the high-CHO diet because they failed to increase insulin sensitivity as did the lean adolescents. Regardless of diet, in obese adolescents, insulin sensitivity was half (P < 0.05) and first- and second-phase insulin secretory indices twice (P < 0.01), compared with the the corresponding values in lean subjects. In obese adolescents, gluconeogenesis increased by 32% during the low-CHO (high-fat diet) (P < 0.01). In obese adolescents, insulin secretory demands were increased regardless of diet. Failure to increase insulin sensitivity while receiving a high-CHO diet required a further increase in insulin secretion, which may lead to earlier beta-cell failure. A low-CHO/high-fat diet resulted in increased gluconeogenesis, which may be a prelude to the increased glucose production and hyperglycemia observed in type 2 diabetics.


  • Open Access

    The Role of Parenteral Lipids in Supporting Gluconeogenesis in Very Premature Infants

    by Agneta L Sunehag

    We have previously demonstrated that very premature infants receiving glucose at 17 μmol/kg min plus appropriate supply of parenteral lipids (Intralipid®) and amino acids (TrophAmine®) maintained normoglycemia by glucose produced primarily via gluconeogenesis. The present study addressed the individual roles of parenteral lipids and amino acids in supporting gluconeogenesis. Fourteen premature infants (993 ± 36 g 27 ± 1 wk) (mean ± SE) were studied for 8 h on d 5 ± 1 of life. All infants were receiving standard TPN prior to the study. At start of study, the glucose infusion rate was decreased to ∼17 μmol/kg min and either Intralipid® (g + AA; n = 8) or TrophAmine® (g + IL; n = 6) was discontinued. Data from 14 previously studied infants receiving glucose (∼17 μmol/kg min) + TrophAmine® + Intralipid® (g + AA + IL) are included for comparison. Gluconeogenesis was measured by [U-13 C]glucose, (g + AA) and (8 infants of the g + AA + IL group) or [2-13C]glycerol, (g + IL) and (6 infants of the g + AA + IL group). Infants studied by the same method were compared. Withdrawal of Intralipid® resulted in decreased gluconeogenesis, 6.3 ± 0.9 (g +AA) vs. 8.4 ± 0.7 μmol/kg min (g + AA + IL) (p = 0.03). Withdrawal of TrophAmine® affected neither total gluconeogenesis, 7.5 ± 0.8 vs. 7.9 ± 0.9 μmol/kg min nor gluconeogenesis from glycerol, 4.4 ± 0.6 vs. 4.9 ± 0.7 μmol/kg min (g+ IL and g + AA + IL groups, respectively). In conclusion, in parenterally fed very premature infants, lipids play a primary role in supporting gluconeogenesis.